Endocyte Inc.

Endocyte Inc.

Endocyte Inc.

Date Founded



3000 Kent Avenue, Suite A1-100, West Lafayette, IN, 47906, USA

Type of Company


Employees (Worldwide)

51 - 100


Hospitals & Patient Services

Company Description

Endocyte, Inc. engages in the development of targeted therapies for the treatment of cancer and inflammatory diseases. It uses a proprietary technology to create novel small molecule drug conjugates and companion imaging diagnostics for personalized targeted therapies. Its small molecule drug conjugates are actively target receptors that are over-expressed on diseased cells. The company was founded by P. Ron Ellis and Philip S. Low on December 6, 1995 and is headquartered in West Lafayette, IN.

Contact Data
Trying to get in touch with decision makers at Endocyte Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees


Chief Medical Officer

Senior Director, Clinical Operations

Vice President-Discovery Chemistry

Vice President of Regulatory Affairs

Vice President of Research

Vice President, Quality

Vice President, Regulatory Affairs

Head of European Clinical Operations


Paths to Endocyte Inc.
Potential Connections via
Relationship Science
Endocyte Inc.
Recent Transactions
Details Hidden

Novartis AG purchases Endocyte Inc.

Details Hidden

Endocyte Inc. issued . USD Common Stock

Details Hidden

Endocyte Inc. issued . USD Common Stock

Transaction Advisors

Advised onEndocyte Inc. issued . USD Common Stock

Escrow Agent

Advised onEndocyte Inc. issued . USD Common Stock


Advised onEndocyte Inc. issued . USD Common Stock

Legal Advisor

Advised onEndocyte Inc. issued . USD Common Stock

Legal Advisor

Advised onEndocyte Inc. issued . USD Common Stock


Advised onEndocyte Inc. issued . USD Common Stock

Advisors & Consultants
Legal Advisor

Chair, Emerging Companies Practice at Dorsey & Whitney LLP

Legal Advisor

Head of US Capital Markets & Managing Partner of Silicon Valley Office at Freshfields Bruckhaus Deringer LLP

Legal Advisor

Partner at Faegre Baker Daniels LLP


General Electric Co. is a technology and financial services company. It operates through the following segments: Power, Renewable Energy, Aviation, Healthcare, and Capital. The Power segment offers technologies, solutions, and services related to energy production, which includes gas and steam turbines, generators, and power generation services. The Renewable Energy segment provides wind turbine platforms, hardware & software, offshore wind turbines, solutions, products & services to hydropower industry, blades for onshore & offshore wind turbines, and high voltage equipment. The Aviation segment provides jet engines & turboprops for commercial airframes, maintenance, component repair, and overhaul services, as well as replacement parts, additive machines & materials, and engineering services. The Healthcare segment provides healthcare technologies in medical imaging, digital solutions, patient monitoring, and diagnostics, drug discovery, biopharmaceutical manufacturing technologies and performance enhancement solutions. The Capital segment leases & finances aircraft, aircraft engines and helicopters, and also provides financial and underwriting solutions. The company was founded by Thomas Alva Edison in 1878 and is headquartered in Boston, MA.

Sumitomo Chemical Co., Ltd. engages in the manufacture and sale of chemicals. It operates through the following segments: Petrochemicals, Energy and Functional Materials Sector, IT-related Chemicals Sector, Health and Crop Sciences Sector, Pharmaceuticals Sector and Others. The Petrochemicals segment consists of synthetic resin, rubber and other resin processed products. The Energy & Functional Materials Sector manufactures and sells battery parts, engineering plastics, synthetic rubber, dye, addition agent, chemical and aluminum products. The IT-Related Chemicals segment sells optical products, color filters, semiconductor processing materials, compound semiconductor materials, and battery components. The Health and Crop Sciences segment distributes fertilizers, pesticides, insecticides, tropical infectious disease control materials, and feed additives. The Pharmaceuticals segment develops and sells ethical pharmaceuticals, radiopharmaceutical, and radiation therapy equipment. The Others segment provides supply of electrical power and steam, design, engineering and construction services for chemical plants, transportation and warehousing services, and conduct of materials and environmental analysis. The company was founded on September 22, 1913 and is headquartered in Tokyo, Japan.

On Target Laboratories LLC develops precise and innovative small molecules whose goal is to target and illuminate cancer and other diseased tissue. The company is headquartered in Northbrook, IL.

Key Stats and Financials As of
Market Capitalization
Total Enterprise Value
Earnings Per Share
Non-Profit Donations & Grants
Details Hidden

Triathlon Medical Venture Partners invests exclusively in the life sciences sector. primarily in the Midwest region. The fund focuses on companies with proprietary technology, unique product, large potential market and experienced management teams. It targets companies operating in the fields of medical device, biotechnology, diagnostic, biopharmaceuticals, genomics, proteomics, regenerative medicine and drug discovery. It acts as a lead investor and provides financing for early and mid to later stage capital requirements with an initial investment size of $0.5 - $3 million and invests up to $7 million per company. It takes a seat on the board of directors and also makes co-investments.

Details Hidden

Burrill LLC invests in companies located in the US and Europe. The firm makes investments in human healthcare therapeutics and diagnostics/devices, health/wellness, agricultural biotechnology, biofuels, industrial biotechnology, biomaterials and bioprocesses with an investment size ranging from $5 million to $15 million. They provide financing for It provides financing for early and later stage capital requirements, acquisitions, and divestitures.

Details Hidden

Blue Chip Venture Co a private equity and venture capital firm, invests in companies located in the US and Canada.They target companies operating in the fields of technology, media & marketing, healthcare and software & services sectors, specialty providers and clinical-stage drug and medical device companies.

Purdue University Government | West Lafayette, usa

Purdue University, located in West Lafayette, Indiana, is the flagship university of the six-campus Purdue University system. Purdue was founded on May 6, 1869, as a land-grant university when the Indiana General Assembly, taking advantage of the Morrill Act, accepted a donation of land and money from Lafayette businessman John Purdue to establish a college of science, technology, and agriculture in his name. The first classes were held on September 16, 1874, with six instructors and 39 students. The university was founded with the gift of $150,000 from John Purdue, a Lafayette business leader and philanthropist, along with $50,000 from Tippecanoe County, and 150 acres (0.6 km²) of land from Lafayette residents in support of the project. In 1869, it was decided that the new school would be built near the city of Lafayette and established as Purdue University, in the name of the institution’s principal benefactor. The West Lafayette campus offers more than 200 majors for undergraduates, over 70 master’s and doctoral programs, and professional degrees in pharmacy and veterinary medicine. In addition, Purdue has 18 intercollegiate sports teams and more than 850 student organizations. Today, Purdue is a member of the Big Ten Conference. Purdue enrolls the second largest student body of any university in Indiana as well as the fourth largest international student population of any university in the United States.

ABX Advanced Biochemical Compounds-Biomedizinische Forschung Medical Products & Equipment | Radeberg, Germany

ABX advanced biochemical compounds-Biomedizinische Forschung, a subsidiary of Meridian Bioscience, Inc., is a German company located in Radeberg. The firm engages in research and development of biochemical compounds. It was founded in 1997. Peter Moll is currently the CEO of the company.

ITM Isotopen Technologien München AG Medical Products & Equipment | Garching, Germany

ITM Isotopen Technologien München AG develops diagnostic and therapeutic radionuclides and radiopharmaceuticals. Its products include EnolucinBeta, 188w/188re generator, 255AC/213Bi Generator, IQS-TS, IQS, consumables, and GMP Radiolabeling service. The company was founded in 2004 and is headquartered in Garching, Germany.

Merck & Co., Inc. Pharmaceuticals - Kenilworth, NJ

Merck & Co., Inc. , d.b.a. Merck Sharp & Dohme, MSD outside the United States and Canada, is an American pharmaceutical company and is one of the largest pharmaceutical companies in the world.

Johnson & Johnson Pharmaceuticals - New Brunswick, New Jersey

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Bausch Health Cos., Inc. Pharmaceuticals - Laval, Canada

Bausch Health Cos., Inc. engages in the development, manufacture, and market of a range of branded, generic and branded generic pharmaceuticals, medical devices and over-the-counter products. It operates through the following segments: The Bausch + Lomb/International, Salix, Ortho Dermatologics and Diversified Products. The Bausch + Lomb/International segment consists of the sale of pharmaceutical products, over-the-counter products, and medical devices products. The Branded Rx segment comprises of pharmaceutical products related to the Salix product portfolio; dermatological product portfolio; branded pharmaceutical products, branded generic pharmaceutical products; over-the-counter products; medical device products; Bausch + Lomb products sold in Canada; and the oncology, dentistry, and health products for women. The Salix Segment consists of sales in the U.S. of GI Products, The Ortho Dermatologics segment consists of sales in the U.S. of Ortho Dermatologics (dermatological) products and global sales of Solta medical aesthetic devices. The Diversified Products segment consists of sales in the U.S. of pharmaceutical products in the areas of neurology and certain other therapeutic classes, in the U.S. of generic products, in the U.S. of dentistry products. The company was founded on March 29, 1994 and is headquartered in Laval, Canada.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Endocyte Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Endocyte Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Endocyte Inc..